Good morning, everyone, and nice to see you again. A busy day is planned here on the Pharmalot corporate campus as we hustle to meet some deadlines and undertake our own version of R&D. No doubt, you relate. So please join us for that mandatory cup of stimulation. Meanwhile, here are some tidbits we found floating about. Hope you conquer the world and see you later...
Will Feds Seek $1B From J&J To Settle Risperdal Suits? (Wall Street Journal)
FDA Panel Discusses Ethics Of Pediatric Drug Trials (MedPage Today)
Pfizer Asked To Fund Advice Line For Employees Losing Jobs (BBC)
Takeda In Talks To Buy Nycomed For $12 Billion (Bloomberg News)
Carl Icahn And His Big Bet On Biotech (The Boston Globe)
Glaxo & Astra Hook Up With Academia For Inflammation Research (Pharma Times)
Experimental AIDS Vaccine Shows Promise In Monkeys (Reuters)
Shire Eyes Big Sales For New Vyvanse Uses (Reuters)
Procrit And Epogen May Worsen Heart Attacks (Health Day)
Docs Busted For Supplying Oxycodone Network (The Star-Ledger of NJ)
Shanghai Pharma To Riase $2 Billion In Hong Kong IPO (Reuters)
Top OxyContin Prescribers In Utah Face Scrutiny (The Salt Lake Tribune)
Thai Regulators Urged To Approve AIDS Meds Faster (Bangkok Post)
EDITOR’S NOTE: Please check this post for updates throughout the morning
Coffee pix thx to chichcacha flickr creative commons
2 Comments
And things come in threes? Docs and Oxycodon, Docs and oxycontin and .. Dilberts Doc, too?
http://dilbert.com/2011-05-12
Old Doc Jackie Lopresti got a five-star rating from her patients on vitals.com. Gues she was doling out scrips for those 40-bars quite liberally.